Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV005097198 | SCV005786270 | likely benign | Neurofibromatosis, type 1 | 2025-12-09 | criteria provided, single submitter | clinical testing | |
| Ambry Genetics | RCV002421456 | SCV002680427 | likely benign | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2020-12-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |